» Articles » PMID: 21764477

Preoperative Lymphocyte Count is an Independent Prognostic Factor in Node-negative Non-small Cell Lung Cancer

Overview
Journal Lung Cancer
Specialty Oncology
Date 2011 Jul 19
PMID 21764477
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

A number of prognostic factors have been reported in non-small cell lung cancer (NSCLC). Although lymph node metastasis is the most poorly predictive value in completely resected NSCLC, a significant number of patients have a fatal recurrence even in node-negative curative NSCLC. Recently inflammatory response has been shown as a predictive value in NSCLC. Neutrophils and lymphocytes play an important role in cancer immune response. In this study, we retrospectively examined the impact of preoperative peripheral neutrophil and lymphocyte counts on survival, and investigated the relationships of these factors to clinicopathological factors in node-negative NSCLC. A total 237 patients were evaluated. When the cut-off value of neutrophil count was 4500 mm(-3) with a maximum log-rank statistical value, overall 5-year survival rates were 79.7% for the low-neutrophil-count group and 69.5% for the high-neutrophil-count group (P=0.04). When the cut-off value of lymphocyte count was 1900 mm(-3) with a maximum log-rank statistical value, overall survival rates were 67.9% for the low-lymphocyte group and 87.7% for the high-lymphocyte group (P<0.001). High-neutrophil-counts were associated with tumor size (P=0.002) and pleural invasion (P<0.001). Low-lymphocyte-counts were correlated with vascular invasion (P=0.018) and recurrence of NSCLC (P=0.01). Multivariate analysis showed that the lymphocyte count was an independent prognostic factor (hazard ratio: 3.842; 95% confidence interval: 1.827-8.078; P<0.001), but the neutrophil count was not (P=0.185). We conclude that a peripheral lymphocyte count, which is associated with vascular invasion, is an independent prognostic factor in node-negative NCSLC.

Citing Articles

Increased ratio of red cell distribution width to lymphocyte percentage as a new preoperative marker for unfavorable survival outcomes in upper tract urothelial carcinoma.

Hsieh Y, Cheng T, Wang C, Hu C, Yang W, Ou C Biomed Rep. 2024; 22(2):32.

PMID: 39720293 PMC: 11668139. DOI: 10.3892/br.2024.1910.


Machine learning approach identifies inflammatory gene signature for predicting survival outcomes in hepatocellular carcinoma.

Al-Bzour N, Al-Bzour A, Qasaymeh A, Saeed A, Chen L, Saeed A Sci Rep. 2024; 14(1):30328.

PMID: 39638834 PMC: 11621542. DOI: 10.1038/s41598-024-81395-x.


The time-series behavior of systemic inflammation-immune status in predicting survival of locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Zhang T, Wang J, Wang D, Xu K, Wu L, Wang X J Natl Cancer Cent. 2024; 2(1):33-40.

PMID: 39035216 PMC: 11256537. DOI: 10.1016/j.jncc.2021.11.003.


Expression of CXCL8 and its relationship with prognosis in patients with non-small cell lung cancer.

Ma X, Zhu X, Zou M, Zhang J, Huang L, Jiang S Am J Cancer Res. 2024; 14(6):2934-2945.

PMID: 39005665 PMC: 11236764. DOI: 10.62347/LJDQ3897.


Unlocking the complete blood count as a risk stratification tool for breast cancer using machine learning: a large scale retrospective study.

Araujo D, Rocha B, Gomes K, da Silva D, Ribeiro V, Kohara M Sci Rep. 2024; 14(1):10841.

PMID: 38736010 PMC: 11089041. DOI: 10.1038/s41598-024-61215-y.